Virbac S.A.
VIRP
Rangering i aksjer
#4511
Founded in 1968 and based in Carros, France, Virbac S.A. is a prominent... Founded in 1968 and based in Carros, France, Virbac S.A. is a prominent developer and distributor of a wide array of animal health products and services. The company's global operations extend across France, Europe, Latin America, North America, Asia Pacific, the Middle East, and Africa, catering to both domestic companion animals and commercial livestock. Its extensive portfolio encompasses vaccines, dental hygiene products, reproductive health solutions, dermatological treatments, parasiticides, diagnostic instruments, antibiotics, and aquaculture offerings. Furthermore, Virbac supplies specialized veterinary pharmaceuticals for anesthesia, geriatric care, behavioral management, and injectable micronutrients, alongside pet food and electronic identification systems. These diverse solutions are designed to support veterinarians, agricultural producers, and individual pet owners worldwide.
Aksjekurs
$389.12
Markedsverdi
$3.26B
Endring (1 dag)
-4.91%
Endring (1 år)
-5.64%
Land
FR
Handel Virbac S.A. (VIRP)
Kategori
Healthcare
Inntekter for Virbac S.A. (VIRP)
Inntekter i Jun 2026 TTM: $265.58M
Ifølge Virbac S.A. sine nyeste økonomiske rapporter er selskapets nåværende resultat $265.58M. I 2023 hadde selskapet et resultat på $192.52M, en økning sammenlignet med resultatet i 2022, som var $189.27M. Resultatet som vises på denne siden er resultat før renter og skatt, eller EBIT.
Inntektshistorikk for Virbac S.A. fra 2002 til 2026
Inntekter ved slutten av hvert år
| År | Inntekter | Endre |
|---|---|---|
| 2026 (TTM) | $265.58M | 22.55% |
| 2024 | $216.71M | 12.56% |
| 2023 | $192.52M | 1.72% |
| 2022 | $189.27M | 10.86% |
| 2021 | $170.73M | -19.12% |
| 2020 | $211.09M | 141.63% |
| 2019 | $87.36M | 83.84% |
| 2018 | $47.52M | -3.41% |
| 2017 | $49.20M | -11.53% |
| 2016 | $55.61M | 250.68% |
| 2015 | $15.86M | -86.85% |
| 2014 | $120.60M | -7.42% |
| 2013 | $130.28M | 3.46% |
| 2012 | $125.92M | 16.49% |
| 2011 | $108.09M | -6.13% |
| 2010 | $115.16M | 42.50% |
| 2009 | $80.81M | 15.08% |
| 2008 | $70.22M | -0.38% |
| 2007 | $70.49M | 41.66% |
| 2006 | $49.76M | 37.75% |
| 2005 | $36.13M | 5.39% |
| 2004 | $34.28M | 0.00% |
| 2003 | 0.00 | 0.00% |
| 2002 | 0.00 | 0.00% |
Inntekter for lignende selskaper eller konkurrenter
| Selskap | Inntekter | Forskjell i inntekter | Land |
|---|---|---|---|
| $33.60B | 12,550.12% |
US
|
|
| $17.74B | 6,578.71% |
US
|
|
| $8.70B | 3,175.53% |
US
|
|
| $5.95B | 2,139.67% |
US
|
|
| $21.39B | 7,953.57% |
CH
|
